Insider Transactions in Q3 2022 at Radius Health, Inc. (RDUS)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 15
2022
|
Machelle Sanders Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,500
-100.0%
|
$55,000
$10.0 P/Share
|
Aug 15
2022
|
Chhaya Shah Chief Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
94,645
-100.0%
|
$946,450
$10.0 P/Share
|
Aug 15
2022
|
Andrew C. Von Eschenbach Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,500
-100.0%
|
$55,000
$10.0 P/Share
|
Aug 15
2022
|
Sean Murphy Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,500
-100.0%
|
$55,000
$10.0 P/Share
|
Aug 15
2022
|
Elizabeth Messersmith Senior Vice President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
70,000
-100.0%
|
$700,000
$10.0 P/Share
|
Aug 15
2022
|
G. Kelly Martin CEO and President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
75,000
-100.0%
|
$750,000
$10.0 P/Share
|
Aug 15
2022
|
Owen Hughes Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
21,650
-100.0%
|
$216,500
$10.0 P/Share
|
Aug 15
2022
|
Danielle Holtschlag Vice President, Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,000
-100.0%
|
$250,000
$10.0 P/Share
|
Aug 15
2022
|
Jean Pierre Garnier Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,500
-100.0%
|
$55,000
$10.0 P/Share
|
Aug 15
2022
|
Jean Pierre Garnier Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
26,800
-82.97%
|
$268,000
$10.0 P/Share
|
Aug 15
2022
|
Cathy Friedman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,800
-100.0%
|
$268,000
$10.0 P/Share
|
Aug 15
2022
|
Willard H Dere Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,895
-100.0%
|
$18,950
$10.0 P/Share
|
Aug 15
2022
|
Willard H Dere Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
21,300
-91.83%
|
$213,000
$10.0 P/Share
|
Aug 11
2022
|
Target N V Biotech > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,733,538
-100.0%
|
$87,335,380
$10.0 P/Share
|
Aug 11
2022
|
Rubric Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,678,954
+16.27%
|
$16,789,540
$10.07 P/Share
|
Aug 10
2022
|
Rubric Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,012
+0.06%
|
$40,120
$10.07 P/Share
|